| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5K | — | +0.0% |
| Cost of Revenue | $2K | — | +0.0% |
| Gross Profit | $3K | — | +0.0% |
| SG&A Expense | $12K | — | +14.0% |
| Operating Income | -$12K | — | -48.0% |
| Pre-tax Income | -$12K | — | -48.0% |
| Net Income | -$12K | — | -48.0% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $29K | +826.6% | +57.7% |
| Accounts Receivable | $39 | — | — |
| Current Assets | $29K | +833.8% | +9.3% |
| Total Assets | $322K | — | +1122.3% |
| Current Liabilities | $573K | +573.1% | +584.7% |
| Total Liabilities | $573K | +573.1% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16K | — | -1121.4% |
| Investing Cash Flow | $30K | — | — |
| Financing Cash Flow | $11K | — | — |
| +584.7% |
| Stockholders' Equity | -$251K | -205.7% | -337.4% |